The 5 biggest themes for investors in 2024
Thu 01 Feb 24, 9:50am (AEST)
MYX ASX Chart
Snapshot
Mayne Pharma (MYX) is a pharmaceutical company focused on commercialising branded women's health and dermatology pharmaceuticals. Mayne Pharma has a 40 year track record of innovation and success in developing new oral drug delivery systems and these technologies have been commercialised in products that continue to be marketed around the world. Mayne Pharma has formulation of complex oral and topical dose forms including release products and poorly soluble compounds.
Share Price Activity (ASX)
| Last (Price) | |
| Change | 0.00 (0.00) |
| Bid / Ask | - |
| Volume | |
| Volume (4w avg) | |
| Turnover | |
| Open | |
| Day Range | - |
| VWAP | |
| Prev Close | |
| Last Trade |
Performance
| 1 Week | |
| 1 Month | |
| 2024 YTD | |
| 1 Year | |
| vs Sector (1yr) | +81.90% |
| vs ASX 200 (1yr) | +70.38% |
Size
|
Market Cap
Excludes mandatory escrowed shares and foreign shares.
|
|
| ASX Rank | 417 of 2,382 |
| Sector Rank | 25 of 226 |
Latest Mayne Pharma Group Ltd News
Announcements
Corporate Overview
Corporate Details
| Head Office | Salisbury South SA 5106 |
| Website | www.maynepharma.com |
| Registry | Computershare |
| Auditor | Ernst & Young |
| Date Listed | 29 Jun 2007 |
Upcoming Calendar (Forecasted)
| Date | Event |
|---|---|
| 29/08/2024 | Report (Prelim) |
| 12/09/2024 | Report (Prelim) |
| 23/10/2024 | Report (Annual) |
| 24/02/2025 | Report (Interim) |
Former Company Names
- Halcygen Pharmaceuticals Limited (HGN), 18/11/2010
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
| Key Data | |
|---|---|
| DPS(TTM) | $0.00 |
| Gross DPS(TTM) | $0.00 |
| Dividend yield |
|
| Gross yield |
|
| Payout Ratio | -- |
| DRP | No |
| DRP Features | -- |
Directors & Management
Directors
Management
Director Transactions
MYX directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of MYX directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
| Name | Last Notice | Total Shares | Shares Held (%) |
|---|---|---|---|
| Viburnum Funds Pty Ltd and subsidiaries and associates | 18/09/2023 | 6,428,268 | 7.70 |
| B L Mathieson | 18/09/2023 | 5,292,066 | 6.30 |
| Rubric Capital Management LP | 18/09/2023 | 4,356,426 | 5.20 |
| The Goldman Sachs Group, Inc. | 12/12/2023 | 5,220,300 | 6.14 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
| Date | Name | Bought | Previous % | New % |
|---|---|---|---|---|
| 08-03-24 | UBS AG and its related bodies corporate | 4,711,962 | -- | 5.54 |
| 01-03-24 | UBS Group AG and its related bodies corporate | 4,783,476 | -- | 5.62 |
| 23-02-24 | UBS Group AG and its related bodies corporate | 4,305,356 | -- | 5.06 |
| 12-12-23 | The Goldman Sachs Group, Inc. | 5,220,300 | -- | 6.14 |
| 24-07-23 | Viburnum Funds Pty Ltd and subsidiaries and associates | 1,123,793 | 6.16 | 7.48 |
| 19-06-23 | The Goldman Sachs Group, Inc. | 6,559,698 | -- | 7.71 |
| 16-06-23 | Rubric Capital Management LP | 4,356,426 | -- | 5.10 |
| 30-05-23 | Viburnum Funds Pty Ltd and subsidiaries and associates | 874,278 | 5.13 | 6.16 |
| 23-05-23 | Lazard Asset Management Pacific Co | 4,265,597 | -- | 5.01 |
| 04-05-23 | Viburnum Funds Pty Ltd and subsidiaries and associates | 4,362,521 | -- | 5.13 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
| Date | Name | Sold | Previous % | New % |
|---|---|---|---|---|
| 14-03-24 | UBS AG and its related bodies corporate | 4,711,962 | 5.54 | -- |
| 07-03-24 | UBS Group AG and its related bodies corporate | 4,783,476 | 5.62 | -- |
| 26-02-24 | UBS Group AG and its related bodies corporate | 4,305,356 | 5.06 | -- |
| 31-10-23 | The Goldman Sachs Group, Inc. | 6,559,698 | 7.71 | -- |
| 21-06-23 | Mithra pharmaceuticals SA and its associates | 168,872,626 | 9.57 | -- |
| 13-06-23 | Lazard Asset Management Pacific Co | 4,265,597 | 5.01 | -- |
| 19-05-23 | Lazard Asset Management Pacific Co | 5,419,443 | 6.32 | -- |
Historical Data
Share Price History
| Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
Historical Data
| Year | Closing Price | Last Trade |
|---|---|---|
| 2023 | $4.40 | 30 June |
| 2022 | $0.250 | 30 June |
| 2021 | $0.320 | 30 June |
| 2020 | $0.385 | 30 June |
| 2019 | $0.510 | 28 June |
| 2018 | $0.870 | 29 June |
| 2017 | $1.09 | 28 June |
| 2016 | $1.91 | 28 June |
| 2015 | $0.985 | 30 June |
| 2014 | $0.850 | 30 June |
MYX Historical
Price Data (CSV)
Up to 20 years of EOD share price history
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
You must be logged in to access this feature.
Please
sign up for free
or
login.
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.